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ABSTRACT
The human mitochondrial genome (mtDNA)
encodes polypeptides that are critical for coupling
oxidative phosphorylation. Our detailed under-
standing of the molecular processes that mediate
mitochondrial gene expression and the structure–
function relationships of the OXPHOS components
could be greatly improved if we were able to trans-
fect mitochondria and manipulate mtDNA in vivo.
Increasing our knowledge of this process is not
merely of fundamental importance, as mutations of
the mitochondrial genome are known to cause a
spectrum of clinical disorders and have been impli-
cated in more common neurodegenerative disease
and the ageing process. In organellar or in vitro
reconstitution studies have identified many factors
central to the mechanisms of mitochondrial gene
expression, but being able to investigate the mole-
cular aetiology of a limited number of cell lines from
patients harbouring mutated mtDNA has been
enormously beneficial. In the absence of a mecha-
nism for manipulating mtDNA, a much larger pool
of pathogenic mtDNA mutations would increase
our knowledge of mitochondrial gene expression.
Colonic crypts from ageing individuals harbour
mutated mtDNA. Here we show that by generating
cytoplasts from colonocytes, standard fusion tech-
niques can be used to transfer mtDNA into
rapidly dividing immortalized cells and, thereby,
respiratory-deficient transmitochondrial cybrids can
be isolated. A simple screen identified clones that
carried putative pathogenic mutations in MTRNR1,
MTRNR2, MTCOI and MTND2, MTND4 and MTND6.
This method can therefore be exploited to produce a
library of cell lines carrying pathogenic human
mtDNA for further study.
INTRODUCTION
The human mitochondrial genome (mtDNA) is a highly
polymorphic molecule found in multiple copies in cells.
The genome encodes 2 ribosomal RNAs and 22 tRNAs that
are essential for translating the 13 mtDNA-encoded polypep-
tides in the mitochondrial matrix (1). Mutations of mtDNA
can cause a wide spectrum of specialized disorders but
have also been linked with common neurodegenerative dis-
ease and the ageing process itself (2–4). Our understanding
of the exact molecular processes that mediate mitochondrial
gene expression has been hampered by our inability to trans-
fect mammalian mitochondria in vivo. Where possible, cell
lines have been established from patients suffering with
mtDNA disease and the cells have been investigated directly,
or after transfer of the patient’s mtDNA to a recipient cell line
devoid of mtDNA (r
0) (5). Studies of such cell lines are
manifold and have given an insight into critical residues of
OXPHOS complexes both in their function and assembly
(6–11), mt-tRNA residues essential for participation in intra-
mitochondrial protein synthesis (12–14) and have led to the
identiﬁcation of a novel mechanism for translation-dependent
decay (15). Given the polymorphic nature of the genome,
however, it is often difﬁcult to determine that a substitution
is indeed pathogenic and is not a neutral polymorphism
(16). This is particularly true for sequence variations in the
two ribosomal RNA genes. In the absence of a transfection
procedure for mitochondria, it is difﬁcult to see how mt-
rRNA nucleotides critical for mitoribosome assembly and
*To whom correspondence should be addressed. Tel: +44 191 222 8028; Fax: +44 191 222 8553; Email: R.N.Lightowlers@ncl.ac.uk
Present address:
Deborah Pye, Division of Metabolic and Cellular Medicine, School of Clinical Sciences, University of Liverpool, Liverpool L69 3GA, UK
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
  2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Nucleic Acids Research, 2006, Vol. 34, No. 13 e95
doi:10.1093/nar/gkl516function might be identiﬁed unless a large library of deﬁned
rRNA mutations was available.
In a recent study, we have shown that human colonic
crypt stem cells accumulate a high level of mtDNA mutations
as a consequence of ageing, resulting in respiratory chain
deﬁciency (17). Many mutations were present in mt-tRNA,
mt-rRNA and structural genes of cytochrome c oxidase
(COX), leading to a mosaic pattern of COX-deﬁciency,
which in some individuals accounted for up to 30% of the
total number of crypts. Moreover, analysis of this tissue
revealed a point mutation proﬁle that is very different from
that observed in patients with inherited mtDNA disease.
Many missense and nonsense mutations in the MTCO genes
were detected in COX-deﬁcient crypts, whereas in the COX-
normal cells there were frameshift and nonsense mutations
in MTND and MTCYB genes that are highly likely to cause
respiratory chain deﬁciency involving either complex I or
complex III, respectively. As it appears that colonic stem
cells can tolerate a high rate of clonal expansion, with little
or no selection against pathogenic mtDNA mutations, our
observations present an opportunity to study in detail the
pathogenic nature of an almost limitless number of mtDNA
mutations provided enough cells can be obtained to perform
meaningful biochemical analysis. Colonocytes can be iso-
lated from colonic sections and can be grown under strict
conditions (18). This is a difﬁcult procedure and the extensive
doubling time of the cultured colonocyte precludes the rou-
tine expansion that would be necessary to produce sufﬁcient
material for standard analytical techniques. Further, success-
ful growth and expansion of colonocytes defective in oxida-
tive phosphorylation have never been demonstrated and
derivedprimarycelllineswouldbepronetosenescence.There-
fore, the generation of a useful library of mtDNA mutations
would only be possible if the mutated mtDNA could be
transferred to immortalized r
0 cells.
In this paper we report the successful production of
transmitochondrial cybrids containing mtDNA from colonic
crypts. These data infer that this method will be useful for
the production of a large library of cell lines harbouring
pathogenic mtDNA mutations.
METHODS
Preparation of human colonocytes
Normal human colonic tissue was obtained from two patients
that had surgical specimens removed as treatment for adeno-
carcinoma. Human colonocytes were prepared according to
the method of Whitehead et al. (18). Brieﬂy, a 1 · 5c m
piece of tissue was trimmed of all muscle and the mucosal
layer was washed in PBS. The tissue was incubated in
0.04% (v/v) sodium hypochlorite in PBS for 15 min to steril-
ize the surface, washed in PBS and then incubated in 3 mM
EDTA plus 0.05 mM dithiothreitol (EDTA/DTT) in PBS for
90 min. After a PBS wash, the sample was shaken vigorously
for 20 s to liberate the crypts from the submucosa. Crypts
were transferred to a centrifuge tube and fresh PBS was
added to the colonic tissue. The shaking step was repeated
for three or four times until the crypt yield diminished.
Crypt suspensions were centrifuged gently at 28 g for
5 min, resuspended in fresh PBS and pooled. After further
centrifugation, the crypts were resuspended in 20 ml of
0.25% pancreatin in PBS and incubated for 90 min. The
cell suspension was diluted with an equal volume of PBS
and centrifuged at 170 g for 5 min. The cell pellet was resus-
pended in EDTA/DTT, pelleted and resuspended in PBS. The
cell suspension was gently drawn through an 18-gauge
needle, then through a 21-gauge needle to disrupt cell aggre-
gates and, thus, a single cell suspension was obtained.
Preparation and fusion of cytoplasts
Cytoplasts were produced by centrifugation on a Percoll
isopycnic gradient according to the method of Trounce
et al. (19). Brieﬂy, 2 · 10
7 colonocytes were resuspended
in 20 ml of 1:1 mixture of Percoll/DMEM, enucleated by
the addition of 20 mg/ml cytochalasin B and centrifuged at
44 000 g for 70 min at 20 C. Cytoplasts were recovered,
diluted and pelleted at 600 g for 10 min. In order to check
the efﬁciency of enucleation during development of the
fusion method, cells were labelled with 1 mM Mitotracker
(Molecular Probes) for 45 min before enucleation and
50 mg/ml DAPI after enucleation.
Cytoplasts were resuspended in DMEM, mixed with 143B
r
0 cells in a 1:1 ratio and centrifuged at 1100 g for 5 min to
form a pellet. DMEM was removed and the cells were
resuspended in 0.8 ml of 50% (v/v) polyethylene glycol
1500 (BDH Limited). After 60 s, the cells were gently resus-
pended in DMEM and left to recover at 37 C for 45 min.
Cells were then plated in DMEM supplemented with
4.5 mg/ml glucose, 10% (v/v) FBS, 100 mg/ml streptomycin,
100 U/ml penicillin, 50 mg/ml uridine, 0.11 mg/ml sodium
pyruvate and 2 mM L-glutamine at a variety of cell densities
(5 · 10
3 to 2 · 10
4 r
0/ml). After 24 h, the medium was
replaced with the supplemented DMEM lacking uridine to
select against unfused r
0 cells. Medium was changed every
3 days and colonies were isolated using cloning rings before
being transferred to 24-well plates for further expansion.
Cell fusions were also carried out with the A549.B2
r
0 lung carcinoma cell line and cytoplasts from the 143B
transmitochondrial cybrids 1.12 and 1.14 using the method
outlined above. Twenty-four hours after fusion the medium
was replaced with DMEM lacking uridine to select against
unfused A549 r
0 cells. The medium was also supplemented
with HAT media to select against non-enucleated 143B
colonocyte cybrids. Clones were isolated as above.
Galactose growth assay for the selection of respiratory
defective clones
All cybrid clones and corresponding parental and r
0 cell lines
were plated in six-well plates at a density of 2.5 · 10
4 cells/
well. Cells were grown in DMEM without glucose (Gibco,
Invitrogen 11966-025) supplemented with 10% (v/v) FCS,
0.9 mg/ml galactose and 0.11 mg/ml sodium pyruvate.
Cells were trypsinized from replicate plates after 3, 5, 7
and 10 days and total cell counts were taken and averaged.
Isolation of total cellular DNA
Cells were washed in PBS, trypsinized and digested overnight
in 1% (w/v) SDS and 2 mg/ml proteinase K at 37 C. The
DNA was puriﬁed by phenol/chloroform extraction followed
by ethanol precipitation.
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PCR was performed with a GenePrint ﬂuorescent STR
Multiplex-GammaST kit (Promega, UK) according to the
kit protocol recommendations. The GammaST kit contained
four short-tandem repeat loci D16S539, D7S820, D13S317,
D5S818 and one of each pair was labelled with ﬂuorescein.
PCR products were separated on a 5% Long Ranger poly-
acrylamide denaturing gel and detected by a laser-based
detection system using the ABI 377 DNA sequencer (Perkin-
Elmer, Warrington, UK). The gel image was analysed using
Genescan 672 version 1.2 software (ABI-PerkinElmer). DNA
fragments were sized using a 60–400 bp ﬂuorescent ladder
(Promega, UK). Data were imported into the Genotyper
version 2.0 software (ABI-PerkinElmer, UK) to convert the
DNA fragment size data into genotypes. Alleles in four loci
were analysed for all samples.
Sequencing of mtDNA
The entire sequence of the mitochondrial genome was
ampliﬁed by a two-stage strategy and a panel of M13-tagged
primer pairs, essentially as described previously (20). PCR-
ampliﬁed products were puriﬁed to remove unincorporated
primer (Montage PCR ﬁlters, Millipore) and sequenced
using BigDye (v3.1) terminator cycle sequencing chemistries
on an ABI 3100 Genetic Analyser (Applied Biosystems).
Sequence chromatograms were directly compared to the revi-
sed Cambridge reference sequence (rCRS) using SeqScape
software (Applied Biosystems). All mtDNA sequence chan-
ges identiﬁed were ﬁrst checked against the MITOMAP data-
base of known, mtDNA polymorphic variants (http://www.
mitomap.org) (21). If changes were not listed in MITOMAP,
a further two databases (http://www.genpat.uu.se/mtDB/
index.html) and that previously held at MitoKor (N. Howell,
personal communication) were checked to verify whether
reported sequence changes were polymorphic or likely to
result in respiratory chain deﬁciency.
Enzymatic assays
Mitochondrial isolation and spectrophotometric assays of
complexes I and IV and citrate synthase activities were
carried out as described previously (22).
Gel electrophoresis and western blotting
Immunodetection analyses were performed on mitochondrial
fractions isolated from the 143B cell lines and both cybrid
clones. Samples (15 mg) were denatured and electrophoresed
on a 15% SDS–polyacrylamide gel before transfer in CAPS
buffer on to Immobilon-P transfer membrane (Millipore) at
a constant current of 300 mA for 3 h. Monoclonal antibodies
against the membrane proteins were purchased from Mito-
Sciences (OR, USA) or Molecular Probes. Mitochondrially
enriched fractions and Blue Native gels were essentially as
described in (23). Brieﬂy, control parental and fused cybrid
cell lines (1 · 10
6 cells per sample) were harvested, washed
in PBS and permeabilized with digitonin (4 mg/ml ﬁnal) at
4 C for 10 min. Five volumes of ice-cold PBS were added
followed by centrifugation at 10000 g for 5 min at 4 C.
Pellets were washed in PBS, resuspended in 1.5 M e-amino
caproic acid, 75 mM Bis–Tris, pH 7.0, solubilized with
n-dodecyl b-D-maltoside and electrophoresed through a
continuous 5–15% acrylamide gel with a 4% stacking gel.
Transfer on to Immobilon membranes was performed in
Towbin buffer for 1 h at 100 V.
Cytochrome spectral analyses
The cell pellets (containing 1.3–2.3 · 10
7 cells) were resus-
pended in 500 ml of 5% (w/v) ﬁcoll and reduced by dithionite.
Spectra were generated by scanning the cell suspensions with
a single beam spectrophotometer built in-house and operating
at room temperature.
Polarographic analyses
Oxygen consumption studies of intact cells were performed
essentially as described previously (24), after resuspension
in a Tris-based Mg
2+-, Ca
2+-deﬁcient buffer (137 mM
NaCl, 5 mM KCl, 0.7 mM Na2HPO4 and 25 mM Tris–HCl,
pH 7.4 at 25 C) and introduction into a high-resolution oxy-
graph chamber (Oroboros, Innsbruck). 2,4-Dinitrophenol
(DNP) was titrated until maximal uncoupling was reached
(30–60 mM), and respiration was inhibited by antimycin
(20 nM). For substrate-speciﬁc respiration, a Tris-based per-
meabilization buffer was used [75 mM sucrose, 5 mM potas-
sium phosphate, 40 mM KCl, 0.5 mM EDTA, 3 mM MgCl2,
0.35% (w/v) BSA and 30 mM Tris–HCl, pH 7.4 at 25 C] and
digitonin was added at a concentration of 15 mg/10
6 cells.
Traces were read after multiple substrate–inhibitor titration
with pyruvate/malate (8/2 mM), glutamate (15 mM) and
rotenone (100 nM), followed by succinate (10 mM) and
antimycin (20 nM). Individual inhibitor-sensitive oxygen
consumption rates were calculated as the time derivative
of the oxygen concentration (DATLAB Analysis Software,
Oroboros) and analysed using SPSS software. Data shown
represent inhibitor-sensitive values as the means ± SD of
3–6 determinations and are expressed in fmol O2/min/cell.
RESULTS
Generation and identification of respiratory-deficient
transmitochondrial cybrids
Human colonic crypts harbour substantial intercrypt
heteroplasmy (mtDNA with sequence divergence). Further,
individual crypts from regions of colon believed to be physio-
logically normally have been shown to carry mtDNA muta-
tions that cause profound defects of cytochrome c oxidase
activity. To determine whether it was possible to trap and
identify these aberrant mtDNA molecules, cytoplasts were
generated from a section of colon taken initially from
donor 1 as detailed in Materials and Methods. Recipient osteo-
sarcoma 143B r
0 cells were prepared and cytoplasts were
fused. After fusion, cells were plated in a medium lacking
uridine (to select against unfused r
0 recipients). After
 2 weeks, the majority of cells had died, with a small num-
ber of clones remaining, potentially carrying mtDNA from
donor 1 cytoplasts. To assess whether these cells were trans-
mitochondrial cybrids, 21 individual colonies were picked
and expanded before DNA isolation as detailed. PCR ampli-
ﬁcation and DNA sequence analysis of the non-coding region
conﬁrmed that the cells contained mtDNA with a sequence
identical to the donor 1 colonic crypts (data not shown).
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mutations that caused a respiratory deﬁciency, clones were
screened for growth on a non-fermentable carbon source.
All clones were expanded and grown as replicas with either
glucose or galactose as a carbon source over a period of
7 days. As shown in Figure 1A, cell counts were variable
between clones but similar trends were seen from two
repeats. Two clones compromised for growth on galactose,
1.12 and 1.14, were taken for further study. First, to conﬁrm
that the nuclear background of the colonocyte cybrids was
from the recipient osteosarcoma cell line alone, DNA was
extracted from cultures of 143B r
0, clone 1.14 and from a
homogenate sample of the colon from donor 1. Genomic alle-
les were compared at four different loci and analysed using
Genotyper software. Figure 2 shows that clone 14 displayed
an identical nuclear genotype to the 143B r
0 cell line and
that the patient colon DNA contained different alleles at all
four loci. As the 143B cells are notoriously aneuploid, the
poor growth could also have been due to a defective gene
in the host nucleus of the recipient clone or to aberrant
gene dosage. Second, to conﬁrm that the lack of growth
was due to the transferred mtDNA, cytoplasts were prepared
from the two clones and fused to a second r
0 cell line, the
lung carcinoma A549.B2. Both resultant transmitochondrial
cybrids were severely compromised for growth on media
containing galactose as a sole carbon source, conﬁrming
that the mutations were indeed mtDNA borne (data not
shown).
Identification of pathogenic mtDNA mutations
captured from colonic crypts
During the production of the A549 cybrids, a colonic sample
was retrieved from a second donor and cybrids were prepared
as detailed above. Similar to the cybrids produced from donor
1, 15 resultant clones showed variable growth on galactose
(Figure 1B). To identify the mutations underlying the respira-
tory defect, total mitochondrial genomic sequencing was
employed on DNA extracted from clones 1.12 and 1.14
plus six putative respiratory-compromised cybrid clones
from the second donor and compared against the sequence
of mtDNA extracted from the donor tissue. Table 1 summa-
rize the base substitutions that were unique to the clones and
Supplementary Tables 1 and 2 list all the sequence variations
from the revised Cambridge Reference Sequence. Clone 1.14
carried a single 5958T>C base transition from the donor
homogenate mtDNA, in MTCOI. RFLP analysis was unable
to detect any remaining wild-type DNA consistent with this
being a homoplasmic mutation (Supplementary Figure 1).
Clone 1.12, in distinction, carried three transitions in rRNA,
two in the gene encoding the 16S mt-rRNA (MTRNR2,
1758T>C;3039T>C) and one encoding the 12S mt-rRNA
(MTRNR1, 1411G>A). In each case, no heteroplasmy was
apparent by sequence analysis. Although we did not formally
assess levels of heteroplasmy for these three sites, in our
experience we have never seen >10% mutation load when
a site appears homoplasmic by sequencing and is then
(A)
(B)
Figure 1. Growth of transmitochondrial cybrid clones on galactose. Cybrids
were generated as detailed in Materials and Methods (A). Twenty-one
individual clones from donor 1 were assessed for growth in galactose. (B)
Fifteen clones were also assessed from a second donor. Cell counts were
performed and averaged from replicate plates after 3, 5 and 7 days (donor 1)
and additionally after 10 days (donor 2). For brevity, cell counts are only
shown for the final time point.
Figure 2. Genotype analysis of clone 1.14 DNA was extracted from cultures
of the recipient 143B r
0, clone 1.14 and from a colon homogenate sample
from donor 1. PCR was carried out as detailed in Materials and Methods
using a fluorescent multiplex GammaSTR kit and PCR products were
separated on a 5% polyacrylamide denaturing gel. The gel image generated
was analysed with Genescan software to determine the sizes of PCR
fragments and Genotyper software was then utilized in order to convert the
fragment size into genotypes. Analysis of the four loci showed that the
genotype of the 143B r
0 cell line is identical to that of clone 1.14 yet different
to the donor colon, confirming the nuclear background of the cybrid.
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From the second fusion, three of the clones contained hetero-
plasmic mtDNA mutations, as judged by repeat DNA
sequence analysis. These mutations were present in different
MTND genes and predicted amino acid replacements in
highly conserved positions. We are unable to conclude that
all six clones derived from donor 2 harboured pathogenic
mtDNA mutations. For conﬁrmation of their pathogenicity,
it would be necessary to re-fuse these cytoplasts into naı ¨ve
r
0 cells, as had been performed with the two clones from
the ﬁrst fusion. In this respect, it is interesting to note that
mtDNA from clone 2.10 was unable to grow on galactose
yet full genome sequencing did not reveal any variation
from the donor’s DNA, consistent with the compromised
growth being due to a nuclear-borne defect.
Analysis of transmitochondrial cybrids
Following conﬁrmation that their mtDNA carried pathogenic
mutations, the two clones 1.12 and 1.14 were expanded and
the mitochondria was isolated for further analysis. For 1.12,
western blots showed a considerable decrease in the steady-
state levels of proteins in complexes I and IV, consistent
with a global mitochondrial translation defect (Figure 3A).
This was supported by the low level of the assembled com-
plexes and in-gel activities as determined by one-dimensional
BN-PAGE (Figure 3B and Supplementary Figure 2). In
contrast, 1.14 which harboured a single mutation in
MTCOI retained normal steady-state levels and activity of
complex I, but BN-PAGE assays showed a profound decrease
Table 1. Unique base substitutions identified in transmitochondrial cybrids
Clone Base substitution* Affected gene Predicted change
1.12 1411 G>A MTRNR1 —
1758 T>C MTRNR2 —
3039 T>C MTRNR2 —
1.14 5958 T>C MTCOI Y19H
2.3 11055 T>A* MTND4 L99Q
2.7 2943 G>A MTRNR2 —
2.10 — — —
2.12 14361 A>G* MTND6 W105R
2.17 5458 T>C* MTND2 I330T
2.19 4647 T>C MTND2 F60L
The entire mitochondrial genomewas sequenced from two and six respiratory-
deficient independent cybrids generated from donors 1 and 2, respectively.
Listed are all the substitutions unique to the cybrids and not present in
mtDNA amplified from donor homogenate. All base substitution differing
from the revised Cambridge Reference Sequence (34) are reported in Supple-
mentary Tables 1 and 2. Asterisks denote that the substitution is present in
heteroplasmic form as confirmed by repeat DNA sequencing. No substitutions
were apparent in mtDNA from 2.10, suggesting that this clone carries an
altered nuclear genotype.
(A)
(B)
Figure 3. Western blot analysis of respiratory-deficient transmitochondrial cybrids. Mitochondrial protein was isolated from 143B.r
0 (r
0), parental (Con) and the
two transmitochondrial cybrids 1.12 and 1.14. (A) Fifteen micrograms were subjected to western blot analysis using antibodies against complex I (nuclear-
encoded 39 kDa or mtDNA-encoded ND6), complex III (nuclear-encoded core 2) and complex IV (mtDNA-encoded COX1 and COX2). All mtDNA-encoded
polypeptides are substantially depleted in clone 1.12, consistent with a general translation defect. Clone 1.14 harboured lower steady-state levels of COX proteins
but were still substantially higher than either the 143B cell line lacking mtDNA (r
0) or 1.12. Equal loading of mitochondrial protein was confirmed with an
antibody specific to the outer membrane protein, porin. (B) A total of 100 mg of protein was subjected to a non-denaturing gel before visualization of intact
complex I and complex IV with anti-39 kDa and COX2 antibodies, respectively. Clone 1.12 is depleted for both holoenzymes, whereas 1.14 has a specific
decrease in complex IV. Minor subcomplexes of complex I can be seen in mitochondria isolated from 1.12.
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Figure 2). This decrease was supported by biochemical anal-
ysis, where complex IV activity when normalized to citrate
synthase was 0.29 compared to 2.13 for the 143B parentals.
Complex I activities were similar (complex I/CS 0.29 cf.
0.32 for parentals). Interestingly, western analysis of 1.14
consistently showed a lower but signiﬁcant level of the
mtDNA-encoded COX subunits I and II. Spectroscopic anal-
ysis of mitochondria isolated from the two clones and con-
trols are shown in Figure 4A. These data are broadly in
agreement with the other assays, showing a profound
decrease of cytochrome aa3 in both clones, with an apparent
sparing of cytochromes bc1 in 1.14 consistent with an assem-
bled complex III that is low or absent in 1.12. Polarographic
studies underline the in vivo consequences on oxidative phos-
phorylation in these cell lines (Figure 4B). Inhibitor-sensitive
oxygen consumption was abolished in the 143B r
0 cell line
(data not shown), and intact cell respiration (ENDO) was
decreased to  14 and 60% in 1.12 and 1.14 cell lines, respec-
tively, when compared to parental controls. When substrate-
speciﬁc respiration was measured in permeabilized cells, 1.14
showed only an approximate 25% reduction in comparison to
the profound complex IV defect measured by spectrophoto-
metric analysis. These data suggest that complex IV exerts
a lower control strength on respiration in 143B cells than
was reported previously (25). This difference may be
explained by the aneuploid nature of this cell line, as a
weaker COX control strength was more recently detailed
(26). In the case of the 1.12 clones respiration studies reiter-
ated the ﬁnding of a global mitochondrial translation defect.
DISCUSSION
Mitochondrial gene expression is essential for life in mam-
mals yet our knowledge of this process is far from complete.
This is in part due to our inability to transfect the mitochon-
drial genome, precluding the testing of many hypotheses. The
molecular analysis of cell lines established from patients has
led to an increased understanding in this area and researchers
have beneﬁted by being able to identify mtDNA mutations
that are undoubtedly pathogenic. However, the number of
cell lines carrying conﬁrmed pathogenic mutations is still
limited. The discovery that we all harbour pathogenic
mtDNA mutations in our colonocytes, often at very high
level is surprising, although variants have previously been
identiﬁed in other tissues and successfully transferred to
r
0 cells. Trounce et al. (27) reported the transfer of murine
mtDNA from neuronal synaptosomes into r
0 cells. Although
a low level of transmitochondrial cybrids contained mtDNA
variants, no pathogenic mutations were identiﬁed. Hayashi
and co-workers (28) also found that synaptosomes in mice
are a useful source of variant mtDNA molecules. In this
case pathogenic mutations were found and have been extre-
mely useful for the production of heteroplasmic mice, but
the mutations identiﬁed were of large-scale mtDNA dele-
tions. These are unlikely to he particularly informative
about the function of speciﬁc nucleotides, as the mammalian
mitochondrial genome is highly compact and large-scale
deletions would invariably remove several vital genes.
Crucially, human colonocytes harbour point mutations of
the mitochondrial genome. Furthermore, sequence analysis
has shown that the spectrum of these mutations is very
different from those currently associated with inherited
mtDNA disease (17). Therefore, in the absence of being
(A)
(B)
Figure 4. Spectrophotometric and polarographic analyses of respiratory-
deficient transmitochondrial cybrids. (A) Whole cell suspensions of
transmitochondrial cybrids 1.12 and 1.14 along with 143B. r
0 and parental
cells were dithionite reduced and scanned at room temperature. Distinct peaks
can be seen corresponding to cytochrome c + c1 (c), b (b) and aa3 (a) for the
143B parental line. There is little evidence of cytochrome aa3 in either of the
clones or the r
0 line a decreased level of complex IV. Cytochrome b
depletion is also noted in 1.12, consistent with defective mitochondrial
translation. (B) Cells (143B parental, clone 1.14, clone 1.12) were suspended
in incubation media and assessed for respiration as detailed in Materials and
Methods. Clone 1.12 exhibits a major decrease in endogenous respiration rate
when compared to the control 143B parental cells. All lines showed a
stimulation of activity on uncoupling of the respiratory chain by dinitrophenol
(UNC). Again, the respiration rate of 1.12 with all respiratory substrates was
substantially reduced, consistent with a defect in mitochondrial translation.
Clone 1.14 showed a decreased rate of respiration when compared to 143B
parentals, but this depletion was not marked, suggesting that complex IV does
not have a major control strength for respiration in these cells.
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our understanding of mitochondrial gene expression it could
be of great importance to try and trap such mutations. In this
report, we have focused on two transmitochondrial cybrids
that are unable to respire efﬁciently. One cybrid, 1.14, carried
a single mutation in the MTCOI gene predicting a Y19H
mutation. Position Y19 is highly conserved between species
and it is clear that Y19H causes a major defect in assembly
of cytochrome c oxidase. Intriguingly, the original paper
reporting the crystal structure of bovine heart cytochrome c
oxidase considered the equivalent residue to be a potential
member of a proton channel (29). Blue native gel and bio-
chemical assays, however, suggest that the mutation does
not impair activity of the assembled complex in the cybrids,
although more detailed study would be needed to completely
preclude such a role for this residue.
A library of mutations in mtDNA-encoded polypeptides
would promote our understanding of structure–function
relationships, but the identiﬁcation of functionally important
residues in the mitochondrial rRNAs is also of great impor-
tance. The second cybrid, 1.12, contained three substitutions
in the MTRNR genes. The mitochondrial genome is extremely
polymorphic, a phenomenon that has been of great use to
evolutionary biologists. This variation, however, has compli-
cated the association of disease with mtDNA mutation. For
example, from 13 nt substitutions or rearrangements in
MTRNR1 that have been associated with maternally inherited
hearing loss, only two have been conﬁrmed to cause disease
(21). These mutations have a very subtle effect on respiratory
function and the defect only seems to be apparent on treat-
ment with aminoglycoside antibiotics. The most common
A1555G substitution occurs close to the 30 end of the 12S
mt-rRNA and is believed to introduce a new base pair at
the base of a stem–loop structure close to the decoding site,
facilitating access of the antibiotic to the ribosomal subunit
leading to impaired or inaccurate translation (30,31).
MTRNR2 encodes the 1558 nt 16S mt-rRNA. This is the
larger mt-rRNA species and 75 polymorphisms are reported
in mitomap alone (21). Only three substitutions, however,
have been associated with disease and none has been con-
ﬁrmed. Therefore, if we are to learn more about critical
regions and nucleotides of mt-rRNAs, it is unlikely that cur-
rent patient cell lines will prove to be a valuable source.
Cryo-EM studies have helped to resolve the human mitoribo-
some to 13.5 s, but although these studies will be useful in
predicting crucial rRNA structures it will be necessary to sup-
port these predictions with direct mutational analyses (32,33).
How, therefore, can we identify critical nucleotides in mt-
rRNAs? The identiﬁcation of the pathogenic mutation in
the second clone 1.12 (and the putative pathogenic mutation
in 2.7) illustrates the power of generating a library of trans-
mitochondrial cybrids from colonocytes, although it is com-
plicated by the concurrence of three individual mutations
all appearing to be present at high levels, consistent with
the mutations being present on the same molecule. A folding
prediction for the human 12S mt-rRNA places the 1411G>A
substitution in the middle of the stem of hairpin 42 in domain
III. This is likely to cause a substantial weakening in the
stem, possibly resulting in a translation defect. Folding pre-
dictions for human 16S mt-rRNA are incomplete, particularly
towards the 50 terminal where 1758T>C is located. This
region, which replaces domain I of the bacterial 23S
homologue, appears to be unstructured and its functional
importance is unclear. The second 16S mutation, 3039T>C
close to the 30 end falls in the loop region of helix 92 in
domain V. This is unlikely to cause a major structural pertur-
bation but it is in an area of strong conservation between
species and, hence, its importance cannot be ruled out. To
be certain of the functional role of these individual
nucleotides it will be necessary to select clones with
mtDNA that carries only one of these mutations. In the
absence of substantial recombination, it is unlikely that this
will be possible for these particular mutations, but the
power of the approach is clear. Identifying crucial residues
in screens of large libraries of colonocyte-derived cybrids
will complement the ever-increasing structural studies of
the mammalian mitoribosome and with the bioinformatics
tools available, a functional proﬁle of both rRNA gene
products will soon be generated.
In summary, we have been able to conﬁrm that the human
colon contains variant mtDNA and a subset of those variants
are pathogenic. These mutations can be trapped as transmito-
chondrial cybrids and as well as generating mutations that
may prove to be informative in structure–function studies
of these OXPHOS components, we believe this approach
will be very useful for mapping critical functional residues
in mitochondrial rRNA genes.
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